Literature DB >> 14688500

Amlodipine and losartan: reaction to comparison.

Gilbert Gleim, Ronald D Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14688500      PMCID： PMC8099218          DOI： 10.1111/j.1751-7176.2003.tb00003.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  8 in total

1.  Effects of losartan titrated to Losartan/Hydrochlorothiazide and amlodipine on left ventricular mass in patients with mild-to-moderate hypertension. A double-blind randomized controlled study.

Authors:  B Martina; T Dieterle; M Weinbacher; E Battegay
Journal:  Cardiology       Date:  1999       Impact factor: 1.869

2.  Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.

Authors:  S Oparil; E Barr; M Elkins; C Liss; A Vrecenak; J Edelman
Journal:  Clin Ther       Date:  1996 Jul-Aug       Impact factor: 3.393

3.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

4.  Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being. LOA Study Group.

Authors:  B Dahlöf; L H Lindholm; S Carney; P J Pentikäinen; J Ostergren
Journal:  J Hypertens       Date:  1997-11       Impact factor: 4.844

5.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

6.  Comparison of losartan and amlodipine in renally impaired hypertensive patients.

Authors:  C Fernández-Andrade; D Russo; B Iversen; P Zucchelli; P Aranda; L Guerra; S Casado
Journal:  Kidney Int Suppl       Date:  1998-12       Impact factor: 10.545

7.  The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.

Authors:  T W Wilson; Y Lacourcière; C C Barnes
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

8.  The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension.

Authors:  Robert A Phillips; Robert A Kloner; Richard H Grimm; Myron Weinberger
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.